m6A Editing: Harnessing CRISPR-Cas for Programmable RNA Modification
…the reversibility of the m6A modification, revealing potential therapeutic targets for m6A dysregulation-related diseases. Abnormal m6A methylation has been implicated in diverse pathologies: diabetes, obesity, neurodegeneration, and cancer, to name…